This site is intended for Healthcare Professionals only
standards-books-1280
bookmark icon off

Raising the standards

New GPhC standards for superintendent pharmacists are expected to be implemented in the coming months after further consultation – but where do their responsibilities end? Solicitors Tracy Sell-Peters and Natasha Ricioppo from Keystone Law explain

Few pharmacists would disagree that superintendent pharmacists should be responsible for the systems they establish and oversee. The more difficult question is where responsibility for governance ends and responsibility for an individual practitioner’s actions begins.

That question lies at the heart of the General Pharmaceutical Council’s (GPhC) proposed standards for superintendent pharmacists. Developed alongside wider pharmacy supervision reforms, the draft standards seek to clarify the superintendent pharmacist’s role, while placing greater emphasis on leadership, governance and organisational culture.

As regulatory expectations continue to evolve, the distinction between a failure of governance and an individual’s misconduct may determine whether regulatory concerns arise at all.

The superintendent’s role

The superintendent pharmacist occupies a unique statutory leadership position within a registered pharmacy business. Unlike the responsible pharmacist, whose duties relate to the safe and effective operation of an individual pharmacy at a particular time, the superintendent pharmacist provides strategic leadership and oversees governance arrangements across the organisation.

The recent supervision reforms attempt to preserve that distinction while enabling the GPhC to define the respective responsibilities of superintendent and responsible pharmacists through standards and rules.

The GPhC’s draft standards identify five principal responsibilities for superintendent pharmacists:

  • Providing strategic and professional leadership
  • Developing a workforce with the necessary skills, knowledge and experience
  • Delegating responsibly and maintaining clear lines of responsibility
  • Establishing and strengthening governance arrangements
  • Ensuring that the pharmacy environment supports safe and effective care.

Taken together, the standards reinforce that the superintendent pharmacist’s role is not to supervise every professional decision personally, but to establish, maintain and continually improve systems capable of delivering safe and effective pharmacy services.

Governance under the spotlight

The proposed standards reflect a broader trend across healthcare regulation. Increasingly, regulators seek to understand not only what happened when something goes wrong, but why it happened. Investigations routinely examine whether appropriate governance arrangements existed, foreseeable risks were identified, concerns were escalated appropriately and lessons learned.

This is not unique to pharmacy. The General Medical Council’s Good Medical Practice and the Nursing and Midwifery Council’s Code both require professionals in leadership roles to promote safe organisational cultures, respond appropriately to risks and support effective governance.

Many would agree that superintendent pharmacists should answer for inadequate governance, ineffective risk management, poor delegation or failures to address known concerns. The more difficult cases arise where appropriate governance systems exist but an individual nevertheless apparently departs from them – for example, by deliberately falsifying records despite robust audit arrangements or repeatedly disregarding established procedures despite appropriate training and supervision.

Important questions

In those circumstances, important regulatory questions may arise, such as whether the superintendent pharmacist discharged their own professional responsibilities for leadership and oversight. Could he/she reasonably have prevented what occurred through the exercise of appropriate leadership, governance and process?

Ultimately, the issue is whether there is a demonstrable connection between the alleged shortcomings and the superintendent’s own discharge of their professional responsibilities. Equally, any assessment must remain proportionate. The standards should support robust governance without creating unrealistic expectations that a superintendent pharmacist can personally prevent every instance of individual misconduct across a large or complex organisation.

What stakeholders are saying

The consultation formed part of the wider implementation of pharmacy supervision reforms, including changes due to come into force in December under the Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025. The GPhC was expected to publish its final standards before those reforms take effect, but the need for further consultation means this will now occur later.

The consultation responses reveal broad support for the direction of travel. The principal debate concerns where the boundaries should be drawn. Several organisations have emphasised that the final standards should continue to recognise the distinct statutory roles of superintendent pharmacists and responsible pharmacists. Others have highlighted the need for the standards to remain proportionate and workable, particularly for multi-site organisations.

What this means in practice

From a regulatory defence perspective, one of the consequences of the proposed standards is likely to be an even greater emphasis on evidence. Regulators will want evidence that governance arrangements operated effectively in practice.

Policies, governance frameworks and standard operating procedures are important, but they rarely tell the whole story. Regulatory investigations frequently turn on contemporaneous evidence showing what decisions were taken, what risks were recognised, how concerns were escalated and what action followed.

For superintendents, the practical implication is clear. It may no longer be enough simply to point to well-designed governance arrangements. They will need to demonstrate, rather than simply assert, that they exercised reasonable leadership and professional judgement, implemented appropriate systems and responded appropriately when risks became apparent.

Superintendent pharmacists should take this opportunity to review not only their governance arrangements, but also how those arrangements are documented and evidenced. Useful contemporaneous records may include governance committee minutes, audit findings, risk registers, records of significant governance decisions, workforce training records, documented delegation arrangements and records showing how concerns were monitored, investigated and resolved. If regulatory scrutiny arises, such records may provide evidence that appropriate leadership and oversight were exercised.

Striking the right balance?

The greatest regulatory risk here may lie not in the absence of appropriate governance, but in the inability to evidence it when questions are later asked. In that respect, the proposed standards reflect a familiar principle across healthcare regulation: those in senior leadership roles will be judged not only by the systems they establish, but by their ability to demonstrate that those systems were actively maintained, reviewed and improved.

The extent to which the new standards will strike the right balance and fulfil the intended objective remains to be seen.

If you need legal advice, contact www.keystonelaw.com

Share:

Change privacy settings